Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 7.3% in the afternoon session after Evercore ISI Group upgraded ...

Evercore ISI upgraded Azenta (AZTA) to Outperform from In Line with a price target of $50, up from $34. Published first on TheFly – the ultimate ...

List today: Azenta, Inc. AZTA provides life sciences solutions, including sample management, genomics services, and laboratory automation for research and clinical markets. The Zacks Consensus ...

Azenta agreed to sell its B Medical Systems unit to Thelema for $63 million, part of the life-sciences company's strategy to simplify its portfolio. Chief Executive John Marotta said Monday that ...

Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the ...

Vale stands out as Bull of the Day after a strong turnaround, rising production and a nearly 7% dividend push shares to new ...

Evercore ISI raised the firm’s price target on Azenta (AZTA) to $50 from $48 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the ...

Azenta (NASDAQ:AZTA) is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable ...

Azenta, Inc. has announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering ...

Recession-related fears were roughing up healthcare stocks Thursday morning. Azenta's underwhelming Q3 earnings report applied additional downward pressure. Shares of diversified life sciences company ...